viernes, 27 de diciembre de 2024

FDA approves nivolumab and hyaluronidase-nvhy for subcutaneous injection

https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-nivolumab-and-hyaluronidase-nvhy-subcutaneous-injection

No hay comentarios:

Publicar un comentario